| scholarly article | Q13442814 |
| systematic review | Q1504425 |
| review article | Q7318358 |
| P50 | author | David A. Isenberg | Q42326409 |
| Antonio Fernandez-Nebro | Q54165674 | ||
| Veronica Rodriguez-Garcia | Q85312550 | ||
| P2093 | author name string | Yiannis Ioannou | |
| Ian P Giles | |||
| P2860 | cites work | The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration | Q27860581 |
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype | Q33329907 | ||
| Anti-prothrombin antibodies: assay conditions and clinical associations in the anti-phospholipid syndrome | Q33337503 | ||
| International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop | Q33685960 | ||
| Value of isolated IgA anti-β2 -glycoprotein I positivity in the diagnosis of the antiphospholipid syndrome | Q33723441 | ||
| Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug | Q33747286 | ||
| A non-complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome. | Q35124036 | ||
| Resistance to annexin A5 anticoagulant activity in women with histories for obstetric antiphospholipid syndrome | Q35490209 | ||
| Evaluating the conformation of recombinant domain I of β(2)-glycoprotein I and its interaction with human monoclonal antibodies | Q35709692 | ||
| Antiphospholipid antibody profile: implications for the evaluation and management of patients | Q37721610 | ||
| The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis | Q37721612 | ||
| Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies. | Q38113521 | ||
| Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review | Q38113968 | ||
| In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of beta2-glycoprotein I: proof of concept | Q40002234 | ||
| Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid syndrome | Q42969030 | ||
| IgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis | Q45126748 | ||
| Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death | Q46373883 | ||
| Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome | Q47225448 | ||
| Thrombin binding predicts the effects of sequence changes in a human monoclonal antiphospholipid antibody on its in vivo biologic actions. | Q51738203 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| systematic review | Q1504425 | ||
| P304 | page(s) | 2042-2050 | |
| P577 | publication date | 2015-07-07 | |
| P1433 | published in | Rheumatology | Q7320492 |
| P1476 | title | Examining the prevalence of non-criteria anti-phospholipid antibodies in patients with anti-phospholipid syndrome: a systematic review | |
| P478 | volume | 54 |
| Q55279180 | A importância de reconhecer a síndrome antifosfolípide na medicina vascular. |
| Q50057538 | Anoctamins/TMEM16 Proteins: Chloride Channels Flirting with Lipids and Extracellular Vesicles |
| Q38885685 | Anti-phospholipid Antibodies and Smoking: An Overview |
| Q64046338 | Antiphospholipid syndrome |
| Q39502759 | Association between antiphospholipid antibodies and arterial thrombosis in patients with rheumatoid arthritis |
| Q51348034 | Clinical performance of antibodies to prothrombin and thrombin in Chinese patients with antiphospholipid syndrome: potential interest in discriminating patients with thrombotic events and non-thrombotic events. |
| Q59133704 | Detection of annexin A8 antibodies in serum of patients with antiphospholipid syndrome |
| Q92594848 | Discovery and characterization of 2 novel subpopulations of aPS/PT antibodies in patients at high risk of thrombosis |
| Q37721340 | Evaluation of Autoantibodies in Patients with Primary and Secondary Sjogren's Syndrome |
| Q39079488 | Evaluation of the clinical relevance of anti-annexin-A5 antibodies in Chinese patients with antiphospholipid syndrome. |
| Q36774243 | Evaluation of the diagnostic potential of antibodies to beta2-glycoprotein 1 domain 1 in Chinese patients with antiphospholipid syndrome |
| Q92146829 | Evaluation of the sensitivity and specificity of a novel line immunoassay for the detection of criteria and non-criteria antiphospholipid antibodies in comparison to established ELISAs |
| Q40115024 | Incidence of thromboembolic events in asymptomatic carriers of IgA anti ß2 glycoprotein-I antibodies. |
| Q38650493 | Investigating in utero fetal death: outcome of the internal medicine consultation |
| Q38865866 | Lupus anticoagulant testing using two parallel methods detects additional cases and predicts persistent positivity |
| Q39198671 | Pathogenesis and management of antiphospholipid syndrome |
| Q89612947 | Prevalence of autoantibodies directed against prothrombin in unprovoked venous thromboembolism |
| Q36421084 | Takayasu Arteritis With Antiphosphatidylserine/Prothrombin Antibody-Positive Antiphospholipid Syndrome: Case Report and Literature Review |
| Q26765406 | The role of anti-phospholipid antibodies in autoimmune reproductive failure |
Search more.